Melanoma risk up in IBD independent of biologic therapy

Melanoma risk up in IBD independent of biologic therapy

(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology and Hepatology.

Siddharth Singh, M.B.B.S., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a of the literature and performed a meta-analysis of 12 cohort studies, involving a total of 172,837 with IBD, to assess the association between IBD and risk of .

The researchers found that IBD was associated with an increased risk of melanoma (12 studies: relative risk [RR], 1.37; 95 percent confidence interval [CI], 1.10 to 1.70). The risk of melanoma was increased in patients with Crohn's disease (seven studies: RR, 1.80; 95 percent CI, 1.17 to 2.75) and patients with ulcerative colitis (seven studies: RR, 1.23; 95 percent CI, 1.01 to 1.50). The risk of melanoma was higher in patients with IBD for studies performed prior to 1998, before biologic therapies were introduced (eight studies: RR, 1.52; 95 percent CI, 1.02 to 2.25), but not for studies performed after 1998 (two studies: RR, 1.08; 95 percent CI, 0.59 to 1.96).

"Based on a meta-analysis, IBD has been associated with an increased risk of melanoma, independent of the use of biologic therapy," the authors write. "Patients diagnosed with IBD should be counseled on their risk for melanoma."

More information: Abstract
Full Text
Editorial

add to favorites email to friend print save as pdf

Related Stories

Inflammatory bowel disease raises risk of melanoma

May 20, 2013

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Stage III/IV melanoma patients at risk for new primaries

Dec 10, 2013

(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower ...

Cancer risk up in bilateral retinoblastoma survivors

Feb 23, 2012

(HealthDay) -- For survivors of bilateral retinoblastoma (Rb), family history is associated with an increased risk of second cancers (SCs), especially melanoma, according to a study published online Feb. 21 ...

Recommended for you

Swatting chikungunya

4 hours ago

Summer days may be waning, but health officials are still on high alert for new cases of chikungunya, a painful mosquito-borne virus that spread to the United States from the tropics earlier this year. ...

Sierra Leone readies for controversial Ebola lockdown

4 hours ago

Sierra Leone prepared Thursday for an unprecedented three-day nationwide lockdown to contain the deadly spread of the Ebola virus in a controversial move which experts claimed could worsen the epidemic.

Nepal adopts jab to boost polio fight

4 hours ago

Nepal on Thursday launched a drive to eradicate polio by supplementing oral vaccines with an injection that experts say will boost children's immunity against the disease.

User comments